VANI
Vivani Medical, Inc.
Biotechnology · Healthcare · United States
1.09
close · 2026-10-30
value
35
cheaper than peers35
quality
7
stronger fundamentals7
ranked against
Biotechnology (pre-revenue)
value
quality
109 peerswide variation
Value inputs
| measure | company | vs peers |
| earnings yield, 3 years ago | -33.0% | 58 |
| earnings yield, 2 years ago | -45.9% | 47 |
| earnings yield, 1 year ago | -39.4% | 46 |
| cash flow yield, 1 year ago | -21.7% | 46 |
| cash flow yield, 3 years ago | -19.5% | 42 |
| cash flow yield, 2 years ago | -25.0% | 40 |
| earnings yield, latest year | -39.4% | 40 |
| cash flow yield, latest year | -25.9% | 39 |
| price to book | 5.14× | 28 |
9 of 12 measures available
Quality inputs
| measure | company | vs peers |
| operating margin | 0.0% | 50 |
| return on equity | -220.4% | 10 |
| debt to equity | 94.1% | 10 |
3 of 4 measures available
Facts
| market cap | $98M |
| free cash flow | -$16.8M |
| employees | 42 |
| first trade | 2014-11-19 |
| next earnings | not reported |
| fundamentals updated | 2026-09-01 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 | 2021 |
| diluted eps | -0.43 | -0.43 | -0.50 | -0.36 | not reported |
| free cash flow | -$25.5M | -$21.3M | -$24.6M | -$19.1M | not reported |
| net income | -$26.6M | -$23.5M | -$25.7M | -$13.9M | not reported |
| revenue | $0 | $0 | $0 | $0 | not reported |
| unusual items | not reported | not reported | not reported | $6.9M | $0 |